BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35531921)

  • 1. α-2,6-sialic acid/IgG anti-dsDNA ratios correlate with human lupus disease activity and possible mechanisms: A pilot study.
    Liou LB; Wang TY; Liu IJ; Wu HC; Ke PY; Fang YF; Chen YF
    Lupus; 2022 Jul; 31(8):927-938. PubMed ID: 35531921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-sialylated and sialylated IgG anti-dsDNA antibodies respectively worsen and mitigate experimental mouse lupus proteinuria and possible mechanisms.
    Liou LB; Chen CC; Chiang WY; Chen MH
    Int Immunopharmacol; 2022 Aug; 109():108837. PubMed ID: 35640407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study.
    Liou LB; Huang CC
    PLoS One; 2016; 11(3):e0151669. PubMed ID: 26981635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients.
    Han J; Zhou Z; Zhang R; You Y; Guo Z; Huang J; Wang F; Sun Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Teng J; Yang C; Ren S; Ye J
    EBioMedicine; 2022 Mar; 77():103883. PubMed ID: 35182998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse expression of α2,6-sialic acid ratios on IgG, IgM, and IgG/IgM autoantibodies correlates with mouse arthritis and rheumatoid arthritis disease activity.
    Liou LB; Huang CC
    J Chin Med Assoc; 2020 Dec; 83(12):1079-1086. PubMed ID: 33009208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
    Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
    Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
    Dai Y; Li E; Chen D; Niu X; Wang Z; Lu L; Zheng B
    Front Immunol; 2022; 13():913714. PubMed ID: 36189276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC; Ho LY; Leung HW; Wong LG
    Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
    Kanda N; Watanabe S
    J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
    Ho A; Magder LS; Barr SG; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.
    Tyrrell-Price J; Lydyard PM; Isenberg DA
    Clin Exp Immunol; 2001 Apr; 124(1):118-25. PubMed ID: 11359450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody clustering helps refine lupus prognosis.
    Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
    Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.
    Cavazzana I; Kumar R; Pozzari C; Ottaviani R; Fredi M; Piantoni S; Andreoli L; Tincani A; Franceschini F
    Lupus; 2019 Aug; 28(9):1074-1081. PubMed ID: 31296140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
    Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.